|Videos|March 23, 2021
Psychedelic Wellness
Author(s)Matt Stang
Early studies find psilocybin shows promise for some psychiatric disorders...
Advertisement
With numerous studies in stage 3 trials, the opportunities to leverage psilocybin for clinical care is likely to expand in the next few years. Matt Stang shares his excitement for the future of this agent as means to help more patients.
To learn more on psilocybin and earn CME credit, see
Mr Stang is the founder of
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves First At-Home Brain Stimulation Device for Treatment of Depression
2
Trontinemab Shows Promise for Treatment of Alzheimer Disease in New Data at CTAD
3
A Computer Expert's Advice On Protecting Chatbot Privacy
4
An Update on the Role of Valproate in Bipolar Disorder
5
